JUser: :_load: Unable to load user with ID: 8856


Persaud-DrGuyanese-born HIV expert Dr. Deborah Persaud was last month named to the TIME magazine list of 2013 World List of “Top 100” Influential People.

Dr. Persaud, a researcher at Johns Hopkins Pediatric in the United States, was propelled into the spotlight in early March when she and doctors Hanna Gay, of the University of Mississippi Medical Center, and Katherine Luzuriaga, of the University of Massachusetts Medical School, announced the first functional cure of HIV in an infant.

The  Florida Department of Health in Miami-Dade County will be celebrating National Nurses Week along with the rest of the nation May 6-12, 2013. This year's theme, “Delivering Quality and Innovation in Patient Care” is significant to our public health nurses who work each day to protect the health of our community.

National Nurses Week begins on May 6, marked as Nurses Recognition Day, and ends on May 12, the birthday of Florence Nightingale, founder of nursing as a modern profession.  The purpose of the week-long celebration is to raise awareness of the value of nursing and help educate the public about the role nurses play in meeting the health care needs of our society.

MIAMI (April 16, 2013) – The Herbert Wertheim College of Medicine at FIU is partnering with the Susan G. Komen for the Cure® Miami/Ft. Lauderdale to promote breast health and early diagnosis and treatment of breast cancer in underserved populations of North Miami Dade.

“This relationship will help us deliver on our mission to address community needs in North Miami,” said Dr. Carolyn Runowicz, HWCOM executive associate dean for academic affairs and a leading expert in cancers that affect women. “The alarming rate of presentation in advanced stage breast cancer will be impacted by this partnership.”

MIAMI (April 16, 2013) -- In a study published in today’s issue of Nature Communications, researchers from Florida International University’sHerbert Wertheim College of Medicine describe a revolutionary technique they have developed that can deliver and fully release the anti-HIV drug AZTTP into the brain.

Madhavan Nair, professor and chair, and Sakhrat Khizroev, professor and vice chair of the HWCOM’s Department of Immunology, used magneto-electric nanoparticles (MENs) to cross the blood-brain barrier and send a significantly increased level of AZTPP—up to 97 percent more —to HIV-infected cells.

For years, the blood-brain barrier has stumped scientists and doctors who work with neurological diseases. A natural filter that allows very few substances to pass through to the brain, the blood-brain barrier keeps most medicines from reaching the brain. Currently, more than 99 percent of the antiretroviral therapies used to treat HIV, such as AZTPP, are deposited in the liver, lungs and other organs before they reach the brain.